Zheng Cao

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 04, 2023
The SGLT2 inhibitor empagliflozin attenuates atherosclerosis progression by inducing autophagy.

Hualin Xu, Jie Fu, Qiang Tu

Pageof 1

Frequent Collaborators